NVAX - NOVAVAX INC
10.8
0.110 1.019%
Share volume: 5,175,757
Last Updated: 03-11-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$10.69
0.11
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-10-2024 | 08-08-2024 | 11-12-2024 | 02-27-2025 | 05-08-2025 | 08-06-2025 | 11-06-2025 | 02-26-2026 | |
| Total revenue | 93.855 M | 415.484 M | 84.512 M | 88.311 M | 666.655 M | 239.240 M | 70.445 M | 147.139 M | |
| Cost of revenue | 59.209 M | 46.242 M | 60.619 M | 36.669 M | 14.115 M | 15.325 M | 21.496 M | 22.104 M | |
| Gross profit | 34.646 M | 369.242 M | 23.893 M | 51.642 M | 652.540 M | 223.915 M | 48.949 M | 125.035 M | |
| 965.76% | -93.53% | 116.14% | 1,163.58% | -65.69% | -78.14% | 155.44% | |||
| Operating expenses | 179.477 M | 208.244 M | 157.911 M | 182.722 M | 137.027 M | 122.845 M | 129.929 M | 109.998 M | |
| Selling general and admin | 86.798 M | 101.298 M | 70.747 M | 78.342 M | 48.090 M | 43.612 M | 31.655 M | 34.122 M | |
| Research and development | 92.679 M | 106.946 M | 87.164 M | 104.380 M | 88.937 M | 79.233 M | 98.274 M | 75.876 M | |
| Total expenses | 179.477 M | 208.244 M | 157.911 M | 182.722 M | 137.027 M | 122.845 M | 226.967 M | 110.805 M | |
| 16.03% | -24.17% | 15.71% | -25.01% | -10.35% | 84.76% | -51.18% | |||
| Operating income | -144.831 M | 160.998 M | -134.018 M | -131.080 M | 515.513 M | 101.070 M | -178.018 M | 14.230 M | |
| Ebit | -141.177 M | 168.729 M | -118.096 M | -65.996 M | 525.569 M | 112.972 M | -168.840 M | 23.727 M | |
| Pretax income | -145.288 M | 164.586 M | -122.332 M | -73.581 M | 519.846 M | 107.454 M | -203.036 M | 17.903 M | |
| -213.28% | -174.33% | -39.85% | -806.49% | -79.33% | -288.95% | -108.82% | |||
| Income tax | 2.262 M | 2.205 M | -1.032 M | 7.449 M | 1.200 M | 946.000 K | -657.000 K | 376.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -147.550 M | 162.381 M | -121.300 M | -81.030 M | 518.646 M | 106.508 M | -202.379 M | 17.527 M | |
| 210.05% | -174.70% | 33.20% | 740.07% | -79.46% | -290.01% | 108.66% |